4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-196313
Chief Executive Officer sold 40,000 shares at an average $70.53 ($2,821,033)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BELANOFF JOSEPH K · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-02 | Sale : show line 1 in the form 10b5-1 | −39,300 | $70.52 | $2,771,326 | 2,822,070 | I |
| 2025-09-02 | Sale : show line 2 in the form 10b5-1 | −700 | $71.01 | $49,707 | 2,821,370 | I |
| Open-market sales · 40,000 sh · avg $70.53 · $2,821,033 | ||||||
Loading xslF345X05/ownership.xml…